BDA advises HLC on investment of Tawada Healthcare

has divested strategic stake to

divested majority stake in

to

acquired majority stake in

has been acquired by

received investment from

a subsidiary of

has acquired

a portfolio company of

has been acquired by

agreed to divest East Syracuse, New York facility to

has sold minority stake to

a portfolio company of

has been acquired by

investment from

has been acquired by

a portfolio company of

has been acquired majority stake by

a portfolio company of

has been acquired by

agreed to divest Couvet, Switzerland facility to WuXi AppTec

raised Series B round from

backed by

has been acquired by

divested Escientia Life Sciences to Deccan Fine Chemicals